Home Pilots Elon Musk’s Neuralink device Blindsight gets FDA breakthrough device designation Pilots Elon Musk’s Neuralink device Blindsight gets FDA breakthrough device designation By - September 19, 2024 24 0 Facebook Twitter Pinterest WhatsApp Blindsight is an experimental implant aimed at restoring vision in individuals who have lost sight in both eyes. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Kindbody, Rightway partner to expand fertility care offerings to employers Pilots - September 26, 2023 0 New AI model for screening gingivitis developed in Hong Kong Pilots - June 16, 2023 0 Workers compensation platform Bardavon Health Innovations scoops up digital MSK startup PeerWell Pilots - June 15, 2022 0 Babylon hires exec to manage international growth and more digital health hires Pilots - September 29, 2022 0 AliveCor rolls out credit card-sized ECG Pilots - February 1, 2022 0 POPULAR CATEGORIESPilots2166Applications750Testing283Collaborations15GitHub3